ORANGE COUNTY, Calif., June 20, 2016 /PRNewswire/ — Spectratech Inc., a Japan-based research and development organization, has created an fNIRS device that touts increased connectivity and monitoring capabilities. Their innovative Spectratech OEG-16H is a mechanism for encephalography that measures changes in hemoglobin and apparent arterial oxygen saturation in the frontal lobe.
The equipment comes with Ultrahigh SNR technology—a Spectratech original development—that can exhibit ultra-weak pulse waves and give users the ability to perform a multi-channel brain localization analysis. Additionally, the device is provisioned with monitor and measurement tools, including an index of Apparent SpO2 (Apparent Arterial Oxygen Saturation), to help researchers better understand how everything from cerebral circulation/metabolism to brain function can be influenced by Ultrahigh SNR technology.
Created to be functional and accessible, the battery-operated device is easily portable with a sleek carrying bag. The bundle includes a main unit, head modules, software, optical phantom, BNC cable for external input, manual event trigger input, USB cable, and AC adapter. Although specially-made software is included, the Spectratech OEG-16 H can run Microsoft Windows 7 or 8 as well.
The instrument facilitates constant connectivity with 6 light injection points, 6 optical light-receiving points, and 16-channel measure points in the lightweight head module. Utilization of this advanced head module is how the device translates brain waves into data. This allows for simultaneous measurement of hemoglobin at multiple points. With the option of a distributor, medical technicians have the ability to implement hyperscanning as well.
Spectratech Inc.’s President, Mitsuo Ohashi, is a Japanese scientist and researcher who specializes in Computer Science and Electronics, specifically in medical imaging technology. During the past 10 years, his passion has predominately been brain mapping, which is evident in his inventive Spectratech OEG-16 H, a type of fNIRS device that captures neurological blood flow.
In the past, medical researchers have worked to establish connections to comatose patients with measurable brain activity through fMRI machines that reveal cortical responses to environmental stimuli such as speech and touch. Spectratech aims to achieve this outcome, but by using fNIRS technology that interprets chemical changes in the brain to establish patterns of communication with comatose patients. Although the gadget is strictly for research, it can facilitate significant advances in the area of functional neuroimaging.
Ampronix has had the pleasure of working with Spectratech Inc., for the last 15 years through our Research and Development department. In fact, we consider Spectratech to be an extension of our own team, as they hold an integral role in our new and existing projects. One of the projects they assist in involves developing circuit design and firmware applications for our original products, like the Scanmaxx.
“Mr. Ohashi has so many different angles of knowledge – for example, just recently, he became involved with neurology,” said Nausser Fathollahi, CEO of Ampronix.
Media Contact: Jamie Nguyen
International Sales: +1 949-273-8000
Domestic Sales: 1800-400-7972 for US and Canada
View our Product Catalog Online Here
Ampronix is a renowned authorized master distributor of the medical industry’s top brands as well as a world class manufacturer of innovative technology. Since 1982, Ampronix has been dedicated to meeting the growing needs of the medical community with its extensive product knowledge, outstanding service, and state-of-the-art repair facility. Ampronix prides itself on its ability to offer tailored, one-stop solutions at a faster and more cost effective rate than other manufacturers. Ampronix is ISO 13485:2003, ISO 9001:2008, and ANSI/ESD S20.20-2007 certified.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.